General
Preferred name
D-serine
Synonyms
(R)-Serine ()
(D)-SERINE ()
DEUTARSERINE ()
C-21692 ()
Ctp-692 ()
P&D ID
PD002617
CAS
312-84-5
62595-04-4
13095-79-9
Tags
drug candidate
natural product
drug
available
Drug Status
experimental
investigational
approved
Max Phase
Phase 2
Phase 3
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Selective GABAA agonist (Tocris Bioactive Compound Library)
DESCRIPTION Glycine mimic active at the strychnine-insensitive glycine binding site associated with the NMDA glutamate receptor as well as the inhibitory post-synaptic glycine receptor (LOPAC library)
Compound Sets
19
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugMAP
Guide to Pharmacology
LOPAC library
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
105.04
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
0
Aromatic Ring Count
0
cLogP
-1.61
TPSA
83.55
Fraction CSP3
0.67
Chiral centers
1.0
Largest ring
0.0
QED
0.39
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
NMDA-Glycine
Pathway
Neuroscience
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Neuronal Signaling
Target
NMDA Receptor
GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3
Endogenous Metabolite
iGluR
NMDAR
Primary Target
NMDA Receptors
MOA
Modulator
NMDA Glycine-Site Agonists
glutamate receptor agonist
Member status
virtual
Source data